NCT07433205

Study on Risk Factors and Prognosis of MASLD

Risk Factors and Prognosis of Metabolic Dysfunction-Associated Steatotic Liver Disease

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 922 (actual)
• Sponsor: First Affiliated Hospital of Chongqing Medical University · Academic / Other
• Sex: All
• Age: 20 Years – 90 Years
• Healthy volunteers: Accepted

Summary

This longitudinal cohort study will enroll individuals with MASLD (and/or those at risk) and follow them over time to identify clinical and metabolic risk factors for disease progression and to evaluate predictors of long-term outcomes, including fibrosis progression and liver-related events, major cardiovascular events, and all-cause mortality.

Conditions

• Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Timeline

• Start date: 2024-01-01
• Primary completion: 2025-12-31
• Completion: 2025-12-31
• First posted: 2026-02-25
• Last updated: 2026-02-25

Locations

1 site across 1 country: China